Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation ...

In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...

Mayo Clinic researchers report that a highly targeted, noninvasive form of radiation therapy reduced episodes of a ...

BACKGROUND: Massive left ventricular hypertrophy (LVH) is a risk factor for sudden cardiac death in children with hypertrophic cardiomyopathy (HCM), but little is understood about its natural history.

Ventricular resection is a type of open-heart surgery to reshape and resize the heart. The surgery may help to improve survival in people with heart failure. Ventricular resection is a surgical ...

This page lists all known medications that could potentially lead to 'Ventricular tachycardia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Ventricular tachycardia arises from an abnormal electrical focus or circuit in the myocardium of the ventricle and is usually manifested as a tachyarrhythmia with a wide QRS complex on ...